awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30730505-D82C247C-24D7-4FA3-B61D-1EC20B4CDA91
Q30730505-D82C247C-24D7-4FA3-B61D-1EC20B4CDA91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-D82C247C-24D7-4FA3-B61D-1EC20B4CDA91
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
P2860
Q30730505-D82C247C-24D7-4FA3-B61D-1EC20B4CDA91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-D82C247C-24D7-4FA3-B61D-1EC20B4CDA91
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c4cb7842cfd07d27ee5e9e570f8fb316b6c1edd
P2860
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.